Bit Bio Discovery GmbH

Founded

2020

Staff

21

Organization type

RDM biotech/pharma

Cluster

LISAvienna

Induced pluripotent stem cell (iPSC) derived cell models offer an extraordinary opportunity to study human disease. We have developed a functional genomics screening platform to query biology within the context of these physiologically relevant cell types. We perturb genes at large scale utilising CRISPR knockout, CRISPR activation and CRISPR interference technologies. Our innovative approach is applicable across a wide range of biological questions and disease areas, including target ID.

R&D:We recognise the critical need for accurate models to enhance drug discovery research. Leveraging our expertise in cell engineering, we provide a comprehensive solution that enables the generation of iPSC-derived cell models customised to our customer’s specific research objectives. By precisely introducing disease-associated mutations or modifying genes of interest, our custom models offer a powerful tool for studying disease mechanisms, identifying and validating therapeutic targets.